Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel for Refractory Seizures in Primary Glioma
NCT02363933Phase 4Completed
- Sponsor
- Duke University
- Start
- Apr 2015
- Primary completion
- Mar 2017
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perampanel in focal onset seizure, sponsored by Duke University. Started Apr 2015; status: completed.
02
Drugs
perampanel
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT02363933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363933.